Ergoloid mesylates vs Efavirenz

Interacting Drugs
Ergoloid mesylates
vs
Efavirenz
Security Level
Major, Avoid combination
Mechanism
Efavirenz: May enhance the adverse/toxic effect of Ergot Derivatives. Specifically, the risk for peripheral vasospasm and ischemia may be increased.
Management
Avoid combination

Subscribe for latest updates

Subscribe to our e-mail newsletter to receive updates.

No comments yet.

Post Review about Ergoloid mesylates vs Efavirenz


Other Interactions of Ergoloid mesylates

We are Developing Our database, More results coming soon.

Other Interactions of Efavirenz

We are Developing Our database, More results coming soon.